LPS administered IP resulted in a robust inflammatory response in our neonatal rats as evidenced by the upregulation of numerous cytokines including IP‐10, a reported bio‐marker of neonatal bacterial infection (Wagner et al. This evidence concerns the gene CXCL10 and bacterial infectious disease.